F

Fujifilm

Global precision manufacturer for healthcare

Principal IAM Engineer

Full-TimeUpdated on 10/23/2026Deadline 11/2/26
No salary listed
Expert
Bachelor's
Hillerød, Denmark
In PersonGlobal position supporting FUJIFILM Biotechnologies sites; home-site location governs benefits and compensation.
CybersecuritySecurity Engineering & Architecture

About the job

Requirements
  • A bachelor's degree in Computer Science, Information Technology, Engineering, Cybersecurity, or a related field, or equivalent professional experience.
  • At least 10 years of IT experience, including at least 6 years focused on identity governance and administration.
  • Hands-on, production-grade configuration experience on a major identity governance and administration platform such as Omada Identity, SailPoint IdentityIQ, SailPoint Identity Security Cloud, or an equivalent platform.
  • Experience leading identity governance and administration platform work as the functional owner, such as an implementation, migration, or major upgrade, rather than only participating in the work.
  • Experience directing specialist or system integrator teams and being accountable for the quality of their deliverables.
  • Product ownership skills, including backlog management, requirements definition, prioritization against available capacity, and stakeholder negotiation.
  • Experience owning joiner-mover-leaver processes, role models, and access request flows in a global enterprise.
  • Experience running access certification campaigns end to end, including revocation follow-through.
  • Experience in a regulated life sciences, pharmaceutical, biotechnology, or comparable GxP environment, including audit and validation support.
  • Working knowledge of Microsoft Entra ID and Active Directory as they relate to provisioning and access governance.
Responsibilities
  • Own the identity governance and administration product backlog by gathering requirements from business, Quality, and Cybersecurity stakeholders, prioritizing work against capacity, and setting the release plan.
  • Translate access policy and control requirements into functional designs, user stories, and acceptance criteria.
  • Make trade-off decisions when certification campaigns, onboarding demand, and deployment work compete for capacity, and communicate those decisions clearly.
  • Own functional testing and user acceptance testing, and represent identity governance and administration in change control and release governance.
  • Report progress, risks, and capacity constraints to IS&O leadership in actionable terms.
  • Perform hands-on configuration and maintenance of the identity governance and administration platform, including policies, workflows, rules, forms, request catalogue, and reporting.
  • Maintain joiner, mover, and leaver configuration for employee, contractor, partner, and service identities.
  • Own the role model, entitlement catalogue, birthright access, and approval flows.
  • Own identity data quality against authoritative sources, including correlation and attribute standards.
  • Act as the senior functional escalation point for provisioning failures, campaign issues, and access-related incidents.
  • Run access certification and recertification cycles, including campaign design, scoping, scheduling, execution, and closure of revocations.
  • Apply role-based access control, segregation of duties, and least privilege in the access model and review scope.
  • Own audit evidence and act as the identity and access management point of contact for internal audits, external audits, and regulatory inspections.
  • Ensure identity governance and administration processes align with applicable GxP expectations, GAMP 5, EU Annex 11, 21 CFR Part 11, and internal policy.
  • Lead functional design and delivery of identity governance and administration platform work, including deployments, upgrades, migrations, and major integrations, aligned with global standards.
  • Own the design and migration of access models, lifecycle processes, and certification approaches during platform changes.
  • Define connector, integration, and data requirements with delivery partners and platform engineering, and validate deliverables through functional testing.
  • Ensure delivery meets validation and change control requirements by design.
  • Plan and sequence application onboarding so changes do not disrupt business access.
  • Direct specialist delivery resources day to day by allocating work, setting expectations, reviewing quality, and unblocking delivery.
  • Bring partners up to speed on the environment, standards, and regulatory obligations so their output meets requirements.
  • Hold delivery partners to scope and quality standards.
Desired Qualifications
  • An IAM or IGA platform certification is strongly preferred.
  • Experience with either Omada Identity or SailPoint is a strong advantage.

About the company

Fujifilm Corporation is the main operating and manufacturing arm of the Fujifilm group, applying its precision chemistry, nanotechnology, and optical engineering to deep-tech and life sciences. It runs Bio CDMO facilities that manufacture biopharmaceuticals and vaccines, makes advanced materials like photoresists and chemical slurries for semiconductors, and develops AI-powered diagnostic imaging devices, endoscopes, and ultrasound systems, while also selling INSTAX cameras and X-Series products. It differentiates itself by applying a long history of precision manufacturing at scale across life sciences, materials, and medical devices rather than focusing on a single niche. Its goal is to turn strategic capabilities into tangible products that advance healthcare, electronics manufacturing, and imaging, maintaining leadership in precision manufacturing and applied science worldwide.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1934

Get referred to Fujifilm

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Oita's August 2026 post-CMP cleaner plant triples capacity for AI semiconductors.
  • Fujifilm's ₹800 crore Dholera plant starts phased investment in October 2026.
  • Dimatix's September 2026 PhaseMaster targets packaging, additive manufacturing, and photovoltaic printing.

What critics are saying

  • FDA recalled Synapse PACS on July 22, 2026, signaling software quality weaknesses.
  • Fujifilm Diosynth's 2025 data-incident settlement exposes cybersecurity liability and customer trust erosion.
  • Polaroid's Instax trade-dress litigation still hangs over Fujifilm's consumer imaging franchise.

What makes Fujifilm unique

  • Fujifilm monetizes proprietary chemistry across semiconductors, healthcare, and imaging.
  • September 2026 Dholera and Oita expansions tighten local supply for critical materials.
  • Rapidus and Tata Electronics partnerships place Fujifilm inside leading-edge manufacturing ecosystems.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Paid Vacation
  • Remote Work Options

Growth & Insights and Company News

6 month growth

-44%

1 year growth

-43%

2 year growth

-43%
Megaproject
Oct 20th, 2026
Sanofi's twin sites win ISPE's overall 2026 Facility of the Year Award.

Sanofi's twin sites win ISPE's overall 2026 Facility of the Year Award. French drugmaker Sanofi took home the top prize last night at the International Society for Pharmaceutical Engineering's 2026 Facility of the Year Award (FOYA) banquet, recognizing biopharmaceutical manufacturing projects for their advances in operations, innovation, supply chain, digitalization, and social impact. Sanofi's twin facilities in Neuville-sur-Saône, France and Tuas, Singapore were selected as a category winner for Innovation - Facility of the Future and also awarded this year's overall FOYA award for exemplifying how the application of advanced digital technologies leads to improved outcomes in terms of safety, product quality, and productivity. Mike Martin, ISPE's president and CEO, said at the dinner ceremony that the overall FOYA award to Sanofi recognizes a global manufacturing project that brings together innovation, flexibility, sustainability, and operational excellence. Sanofi's twin facilities in France and Singapore "stood out for reimagining what modern biomanufacturing can be," according to Martin, who noted the company's dual-site approach was "designed as a fully modular, digitally native platform" enabling multiple vaccines and biologics to be produced within a single facility while "dramatically" reducing changeover time. ISPE called out the Sanofi Modulus platform for its "plug-and-produce" modular architecture, allowing manufacturing lines to be rapidly reconfigured for different products or processes - with new equipment modules simply moved in and connected to pre-installed utility, data, and control interfaces. "Advanced automation, artificial intelligence, real-time analytics, and predictive technologies are integrated throughout the operation, creating a manufacturing model built for speed, resilience, and future demand," Martin added. "This project represents a new standard for flexible and intelligent biomanufacturing." FOYA judge Gunter Baumgartner, senior vice president and head global engineering at Takeda Pharmaceuticals, said Sanofi's Modulus project includes a rare combination of "visionary design, operational brilliance, and a deep commitment to improving patient outcomes" that "not only meets the moment but defines the future." Liang Hong Koh, Singapore site head, Modulus Sanofi, thanked ISPE for the "tremendous recognition" to be selected as the overall 2026 FOYA. With the Modulus platform, he said Sanofi succeeded in the simultaneous design and construction of two facilities - a greenfield campus in Tuas and an expansion of its Neuville-sur-Saône site - that are adaptable and flexible in manufacturing. Pointing to this year's other FOYA category award winners, he commented that the biopharma industry "can achieve remarkable things when we challenge ourselves to do things differently and to think differently." The banquet kicked off this year's ISPE Annual Meeting & Expo in the Washington, D.C. area, with awards to category winners including AstraZeneca, BSP Pharmaceuticals, Eli Lilly, Hepalink Pharmaceutical Group, and Takeda - with honorable mention to Chugai Pharma Manufacturing and Fujifilm Biotechnologies. Bayer's SOLIDA-1 site in Leverkusen, Germany won two separate FOYA awards - Operations - Operational Excellence and Pharma 4.0 - for its integration of modular design, end-to-end automation, and digital manufacturing architecture. The German site includes autonomous material flow and connected-data systems, improving equipment effectiveness and reducing manual intervention while supporting scalable oral solid dose production, according to ISPE. [email protected] As Editor in Chief, Greg oversees all aspects of planning, managing, and producing the content for Pharma Manufacturing's website and digital products, as well as the daily operations of its editorial team. For more than 20 years, Greg has covered the healthcare, life sciences, and medical device industries for several trade publications. He is the recipient of a Post-Newsweek Business Information Editorial Excellence Award for his news reporting and a Gold Award for Best Case Study from the American Society of Healthcare Publication Editors. In addition, Greg is a Healthcare Fellow from the Society for Advancing Business Editing and Writing. When not covering the pharma manufacturing industry, he is an avid Buffalo Bills football and Buffalo Sabres hockey fan, likes to kayak, and plays guitar. Topics: Factory Was this helpful to you?

News On Japan
Oct 20th, 2026
Japan's chip technology to accelerate AI medical imaging.

Japan's chip technology to accelerate AI medical imaging. Oct 20, 2026 | News On Japan TOKYO - A Japanese semiconductor research consortium involving Rapidus and Fujifilm has announced plans to develop an artificial intelligence system for processing medical images using cutting-edge 2-nanometer chips, aiming to significantly improve processing speeds while reducing power consumption to support real-time diagnosis and surgical procedures. The Leading-edge Semiconductor Technology Center (LSTC), a technology research association that includes advanced chipmaker Rapidus, will collaborate with Fujifilm and other partners to develop the system, which is designed to handle complex medical imaging tasks more efficiently. By incorporating state-of-the-art 2-nanometer semiconductors, the developers expect to achieve substantial improvements in computing performance while keeping energy consumption low, addressing two critical requirements for advanced AI applications in healthcare. The system is intended to accelerate the processing of medical images, enabling doctors to analyze information in real time during examinations and surgical procedures. Faster image processing could improve the speed and efficiency of medical diagnosis and provide surgeons with more immediate information during operations. The project is being developed with the planned use of 2-nanometer chips that Rapidus is expected to manufacture under contract for U.S. technology company IBM in the second half of fiscal 2027, which runs through March 2028. The collaboration represents an effort to apply Japan's next-generation semiconductor technology to medical AI, combining advanced chip manufacturing with healthcare imaging expertise to support faster and more efficient medical services.

ChannelNews
Oct 20th, 2026
Fujifilm Instax Square 2 appeals with analogue colour filters & new Soft Haze film.

Fujifilm Instax Square 2 appeals with analogue colour filters & new Soft Haze film. Emma Wheaton | 20 Oct 2026 Fujifilm is refreshing its square-format instant camera range with the Instax Square 2, a new analogue model that lets shooters use physical filters to change the colour tone of their photographs, rather than relying on digital effects. Announced in October, the Instax Square 2 has a redesigned body, warm and cool colour settings to choose from, and a new instant film option for those photographers after softer and more atmospheric images. The camera is scheduled to launch from 28 October, with US pricing starting at US$119.95. Australian pricing and availability have not yet been confirmed. Unlike hybrid instant cameras that combine digital photography with printing, the Square 2 has a fully analogue shooting experience. Users compose their images through an optical viewfinder, take the photograph and get a physical instant print on the Instax Square film. The biggest addition to the new model is Fujifilm's Mood Filter Switch, which allows photographers to choose between Warm, Cool and Off settings before taking a picture. Warm adds a subtle golden hue, while Cool adds a bluer tone. Switching the filters off keeps the standard Instax film look. The filters sit in front of the lens, meaning the colour effect is physically applied during capture and not through software after the photo has been taken. It's an approach that gives the Square 2 a different appeal from smartphone photography, where filters are typically applied digitally and images can be edited extensively before sharing. The camera also features automatic exposure and flash adjustment, as well as a rotating lens ring that selects Standard, Close-up or Landscape shooting modes, and a built-in selfie mirror. Fujifilm has redesigned the camera with a rounded body. It will be available in three colours: Slate Blue, Misty White and Brick Red. Alongside the launch of the Square 2 is the release of a new film option, the Instax Square Soft Haze, which delivers lower colour saturation and contrast, glowing highlights and warm, diffused shadows. The film is intended to create a softer appearance, free from digital manipulation. Each pack contains 10 exposures, with US pricing set at US$18.99. Soft Haze is compatible with existing Instax Square cameras, so owners of earlier models can experiment with the new film without buying the Square 2. The standard Square format produces square photographs measuring approximately 62mm by 62mm within the film's larger frame. Instant cameras continue to appeal to travellers, younger photographers and people who prefer physical keepsakes to digital photo libraries. However, film costs are an important consideration. With 10 exposures per Soft Haze pack, each photograph represents a consumable expense, which arguably is part of the appeal. It invites photographers to slow down, be more creative and be more conscious of what and how they shoot. Fujifilm has not yet confirmed Australian pricing or a local release date for either of the new products.

Fuji Rumors
Oct 19th, 2026
New Fujifilm X-T6 NP-W255 battery compatible with older camera models.

New Fujifilm X-T6 NP-W255 battery compatible with older camera models. Back in June Fujirumors shared the rumor that along with the Fujifilm X-T6, Fujifilm will also launch a new NP-W255 battery. * New: NP-W255 - 2,550 mAh * Old: NP-W235 - 2,200 mAh And Fujirumors also calculated a 10% capacity increase over the old NP-W235 battery. Back then the main question I was getting was if the new NP-W255 can be used also on older models currently using the NP-W235. Well, I am pleased to announce that according to its trusted sources the new NP-W255 will be compatible with every Fujifilm camera currently using the NP-W235. So, if you want to squeeze out a bit more battery life from your current X-T5 & Co, you can get the new Fujifilm NP-W255. * fujirumors.com - Fujifilm NP-W126S Battery Counterfeits - A Visual Guide to Spotting the Fakes * fujirumors.com - The Ultimate Fujifilm NP-W126S vs Third Party Batteries Battle * fujirumors.com - Powering the Fujifilm X-T3 * fujirumors.com - TESTED: Third Party Fuji Batteries? "Inflated capacity values. Some batteries almost Fraud!"... and the Winner is...? * fujirumors.com - 13 Different Batteries for Fujifilm Compared * fujirumors.com - Fujifilm NP-W126 Vs. Third Party Batteries compared * fujirumors.com - Practical Nitecore dual travel battery charger for Fujifilm. One of top 5 sellings products on Fujirumors in 2018. Check out its 2018 top sellers here. * fujirumors.com - JJC is offering a practical (and cheap) dual USB battery charger for Fujifilm NP-W126/S batteries * fujirumors.com - Finally: Fujifilm NP-W126S Third Party Battery Available! * fujirumors.com - Top 7 Essential Things You Should Take With You On Your Travels! **This post contains affiliate links and I will be compensated if you make a purchase after clicking through my links. As an Amazon Associate I earn from qualifying purchases

Associated Press
Oct 19th, 2026
ePac and Fujifilm partner to roll out J Press FP790 digital inkjet across 20+ global plants

ePac Flexible Packaging has formed a global strategic alliance with Fujifilm's Graphic Communication Division, announced on October 19, 2026. ePac will deploy Fujifilm's J Press FP790, a water-based digital inkjet press built for high-volume flexible packaging. The rollout begins at ePac's new facility in Phoenix, Arizona, with more of its global network to follow in later phases. The press prints at 1200 x 1200 dpi and covers over 90% of the Pantone® colour gamut. It uses food-safe water-based inks and supports recyclable materials. ePac says the press will raise throughput while keeping its short-run, on-demand capabilities. "We are significantly increasing our capacity and capability to handle larger run lengths efficiently," said Parag Patel, president of shared services at ePac. ePac, founded in 2016, operates more than 20 facilities worldwide.